Previous close | 0.0300 |
Open | 0.0300 |
Bid | 0.0000 |
Ask | 0.0600 |
Strike | 95.00 |
Expiry date | 2024-06-21 |
Day's range | 0.0300 - 0.0300 |
Contract range | N/A |
Volume | |
Open interest | 310 |
Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Johnson & Johnson (JNJ) closed the most recent trading day at $146.76, moving -0.25% from the previous trading session.
Johnson & Johnson has agreed to pay $700 million to settle an investigation by 42 U.S. states and Washington, D.C. into its marketing of baby powder and other talc-based products blamed for allegedly causing cancer. The settlement resolves charges that Johnson & Johnson misled consumers into believing its talc products, which it sold for more than a century before stopping, were safe. J&J did not admit wrongdoing in settling with the states, which were led by Florida, North Carolina and Texas, and has said its talc products are safe and do not cause cancer.